Our Financial & Valuation Services
Finance in innovative Life Science and IP-driven high-risk innovation
In life sciences and deep tech, the one who invents is rarely the one who finances. Uncertainty is the starting condition, though not perceived the same way by all stakeholders.
On any innovative journey, one question sits ahead of every other: who can put a price on this, what price, and why? Governance, leverage, optionality, risk — all of it follows from the answer.
We work that question through three moments: before a price exists, while it's being agreed, and after it has to hold.
✽ Upon yours needs
Finance structures the innovative journey
Whatever the company, asset or liability — a licence, a convertible, an option pool, an IP transfer, an IPO, a trade sale, a merger of equals — the question is the same: the party who can price it is the party who buys in. So in each specific case: who can price it, what terms are proposed, and why.
We read the context, and find the way, the number, and the narrative.
When critical decisions near, management teams of companies and funds walk through three steps, with the board sitting in the middle:
Positionning
Work out what it's worth, to whom and why
The value and pricing logic behind an R&D arbitrage, a raise, a licence, a JV, a merger, an exit, or an incentive plan — set before anyone's asked to commit to it.
Value and value development analysis · Modeling for decision · Context framing · Readiness assessment · Comparators digest · Alignment of stakeholder terms · Fairness opinion · Transfer price
We read what the financials or the cap table can't show yet — before anyone sits down to negotiate.
ANTICIPATION - PREPARATION
Negotiation
Investment decisions in the making
Term sheet, negotiation, transaction, board sign-off — the moment a number stops being a hypothesis and becomes a position.
Term sheet analysis · Investor- or industry-driven modeling · Deal structuring · Pricing power and negotiation margin · Narrative optimization · Value of intangibles · Fair value · Best value
Price is the floor. We work on it, and on what sits above it.
NEGOTIATION - ARBITRAGE - DECISION MAKING
Control
Efficient monitoring
Booked, reported, revisited — the value now has to work in practice, not just on paper.
Contingent obligations - incentive plan - value development
Fair value accounting · Sanity-check · Modeling of complex incentives or contingent payment contracts · Sensitivity and deviation analysis · Risk mitigation and emerging opportunity
The event closes. The fair value accounting keeps it open.
IMPLEMENTATION - MONITORING - AMENDING
Independent, by nature of the role
Our work is scoped to the situation — without dependency:
A focused intervention, when clarity is required
Continued analytical support across key stages, ahead of transitions
A sparring role alongside management, boards or investors
Fair value accounting and modeling support